secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOADAPTIVES, INC. (BDPT)
CIK:        0001575142
Form:       8-K
Filed at:   2024-11-27T23:59:59+00:00
Accession:  0001640334-24-001796
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAdaptives gets IRB approval for human trial of weight management product Zeranovia
--------------------------------------------------------------------------------

- IRB approved human clinical trial for Zeranovia, a weight management supplement.
- First phase to confirm dosing and identify side effects; participant slots quickly filled.
- CEO notes less than 1% of nutraceuticals undergo human trials; aims for scientific proof.
- Trial managed by doctors in Las Vegas, NV; next stage open to more participants.
- If successful, Zeranovia could compare favorably to synthetic GLP-1 and GIP treatments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1575142/000164033424001796/0001640334-24-001796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1575142/000164033424001796/bdpt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-001796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer